Qcm Cayman, Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Qcm Cayman, Ltd.

$9.06 Million
Q2 2024

A detailed history of Qcm Cayman, Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Qcm Cayman, Ltd. holds 201 shares of REGN stock, worth $209,470. This represents 2.33% of its overall portfolio holdings.

Number of Shares

201

Holding current value

$209,470

% of portfolio

2.33%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $177,523 - $215,309	201 New	201 $211,000
Q3 2023 Oct 30, 2023	SELL	$692.45 - $844.37 $103,867 - $126,655	-150 Reduced 36.95%	256 $210,000
Q2 2023 Jul 25, 2023	BUY	$700.03 - $830.35 $284,212 - $337,122	406 New	406 $291,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $242,215 - $305,663	422 New	422 $291,000
Q2 2022 Jul 27, 2022	SELL	$548.35 - $738.84 $281,303 - $379,024	-513 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $42,848 - $50,286	72 Added 16.33%	513 $358,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $239,674 - $295,897	441 New	441 $279,000
Q3 2021 Nov 01, 2021	SELL	$574.03 - $680.96 $257,739 - $305,751	-449 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $212,287 - $250,784	449 New	449 $251,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $198,322 - $259,882	-553 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $18,117 - $21,168	-42 Reduced 7.06%	553 $247,000
Q2 2017 Aug 14, 2017	BUY	N/A	595	595 $292,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.37 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.8 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.63 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.05 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.83 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Qcm Cayman, Ltd. with notifications on news.

Account